Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
Radiation Oncology Journal. 2021;39(2):113-121 
Combination of Yttrium-90 Radioembolization With Stereotactic Body Radiation Therapy in the Treatment of Portal Vein Tumor Thrombosis
International Journal of Radiation Oncology*Biology*Physics. 2021;111(3):e54-e55
Hepatocellular carcinoma with portal vein tumor thrombosis: Improved treatment outcomes with external beam radiation therapy
Hepatology Research. 2011;41(9):813-824
Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: The Emerging Role for Radioembolization Using Yttrium-90
Oncology. 2013;84(5):311-318
An Alternative Therapy for HCC with Portal Vein Tumor Thrombosis: Y-90 Radioembolization
World Journal of Surgery. 2013;38(5):1246-1246
Concurrent transarterial radioembolization and combination atezolizumab/ bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case report
Journal of Liver Cancer. 2022;22(1):69-74
A Preliminary Analysis of Robotic Radiosurgery Stereotactic Body Radiation Therapy With or Without Sorafenib for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
International Journal of Radiation Oncology*Biology*Physics. 2017;99(2):E180
Comparison of Clinical Efficacy after Stereotactic Ablative Radiation Therapy with Conventionally Fractionated Radiation Therapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
International Journal of Radiation Oncology*Biology*Physics. 2018;102(3):e65
Patterns of Care and Effectiveness of Stereotactic Body Radiation Therapy and Yttrium-90 Radioembolization in Unresected Hepatocellular Carcinoma: An NCDB Analysis
International Journal of Radiation Oncology*Biology*Physics. 2018;102(3):e63
Stereotactic Body Radiotherapy Versus Intensity-Modulated Radiotherapy For Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
. 2021;